| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |